Question 69 (part 2) · LEK · Acromegaly
Which is a biomarker of significant use in the diagnosis and monitoring of somatotrophic pituitary adenomas?
- A. somatoliberin.
- B. insulin-like growth factor 1.
- C. tumour necrosis factor alpha.
- D. transforming growth factor beta.
- E. somatostatin.
Hint
Growth hormone acts largely through a liver-derived mediator whose level is stable throughout the day.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Internal medicine
- Which is a biological drug used in the treatment of autoimmune diseases (including rheumatoid arthritis) that prevents the second signal in the…
- The list below includes selected diagnostic factors or symptoms that allow the diagnosis and assessment of the activity of rheumatoid arthritis…
- The list below includes clinical domains of the EULAR/ACR criteria for the classification of systemic lupus erythematosus. The patient scores…
- The only biological drug (anti-body) registered for the treatment of systemic lupus erythematosus is:
- Which of the following drugs used in the treatment of chronic obstructive pulmonary disease are short-acting:
- In 70% of patients with primary sclerosing cholangitis the disease is accompanied by: